OA10712A - 1,4-Dihydropyridine compounds as bradykinin antagonists - Google Patents

1,4-Dihydropyridine compounds as bradykinin antagonists Download PDF

Info

Publication number
OA10712A
OA10712A OA9800111A OA9800111A OA10712A OA 10712 A OA10712 A OA 10712A OA 9800111 A OA9800111 A OA 9800111A OA 9800111 A OA9800111 A OA 9800111A OA 10712 A OA10712 A OA 10712A
Authority
OA
OAPI
Prior art keywords
dimethyl
dihydropyridine
dichlorophenyl
carbonylmethyl
oxo
Prior art date
Application number
OA9800111A
Other languages
English (en)
Inventor
Takafumi Ikeda
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA10712A publication Critical patent/OA10712A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
OA9800111A 1996-02-19 1998-07-10 1,4-Dihydropyridine compounds as bradykinin antagonists OA10712A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9600132 1996-02-19

Publications (1)

Publication Number Publication Date
OA10712A true OA10712A (en) 2001-06-04

Family

ID=11004406

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9800111A OA10712A (en) 1996-02-19 1998-07-10 1,4-Dihydropyridine compounds as bradykinin antagonists

Country Status (34)

Country Link
US (1) US6131226A (cs)
EP (1) EP0882044B1 (cs)
JP (1) JP3167335B2 (cs)
KR (1) KR19990082678A (cs)
CN (1) CN1211251A (cs)
AR (1) AR005841A1 (cs)
AT (1) ATE220676T1 (cs)
AU (1) AU1396497A (cs)
BG (1) BG102678A (cs)
BR (1) BR9707568A (cs)
CA (1) CA2245857C (cs)
CO (1) CO4650041A1 (cs)
CZ (1) CZ258698A3 (cs)
DE (1) DE69714019T2 (cs)
DK (1) DK0882044T3 (cs)
ES (1) ES2177921T3 (cs)
HN (1) HN1997000013A (cs)
HR (1) HRP970094A2 (cs)
HU (1) HUP9902810A3 (cs)
ID (1) ID16434A (cs)
IL (1) IL124867A0 (cs)
IS (1) IS4783A (cs)
MA (1) MA26419A1 (cs)
NO (1) NO983776D0 (cs)
NZ (1) NZ325455A (cs)
OA (1) OA10712A (cs)
PE (1) PE36298A1 (cs)
PL (1) PL328514A1 (cs)
PT (1) PT882044E (cs)
SI (1) SI0882044T1 (cs)
TN (1) TNSN97037A1 (cs)
TR (1) TR199801593T2 (cs)
WO (1) WO1997030048A1 (cs)
ZA (1) ZA971357B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11106375A (ja) * 1997-08-18 1999-04-20 Pfizer Pharmaceut Inc ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物
US6653313B2 (en) * 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
GB0427281D0 (en) * 2004-12-14 2005-01-12 3M Innovative Properties Co Methods of providing medicinal metal components having through holes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120750A (en) * 1989-01-17 1992-06-09 Synphar Laboratories, Inc. Generation of 1,4-dihydropyridine derivatives
WO1996006083A1 (en) * 1994-08-24 1996-02-29 Pfizer Pharmaceuticals Inc. 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists
MX9701245A (es) * 1996-02-19 1998-04-30 Pfizer Compuestos de 1,4 dihidropiridina.

Also Published As

Publication number Publication date
PT882044E (pt) 2002-11-29
CA2245857C (en) 2002-10-01
KR19990082678A (ko) 1999-11-25
PL328514A1 (en) 1999-02-01
CZ258698A3 (cs) 1999-06-16
ZA971357B (en) 1998-08-18
TR199801593T2 (xx) 1999-12-21
JP3167335B2 (ja) 2001-05-21
TNSN97037A1 (fr) 2005-03-15
CA2245857A1 (en) 1997-08-21
ES2177921T3 (es) 2002-12-16
DE69714019D1 (de) 2002-08-22
MA26419A1 (fr) 2004-12-20
US6131226A (en) 2000-10-17
CO4650041A1 (es) 1998-09-03
HRP970094A2 (en) 1998-06-30
CN1211251A (zh) 1999-03-17
AR005841A1 (es) 1999-07-14
IL124867A0 (en) 1999-01-26
PE36298A1 (es) 1998-07-18
DK0882044T3 (da) 2002-09-02
NO983776L (no) 1998-08-18
ATE220676T1 (de) 2002-08-15
HUP9902810A3 (en) 2000-09-28
HN1997000013A (es) 1997-06-26
HUP9902810A2 (hu) 2000-05-28
AU1396497A (en) 1997-09-02
BG102678A (en) 1999-04-30
ID16434A (id) 1997-09-25
NO983776D0 (no) 1998-08-18
DE69714019T2 (de) 2002-11-14
WO1997030048A1 (en) 1997-08-21
JPH11507949A (ja) 1999-07-13
IS4783A (is) 1998-06-25
NZ325455A (en) 1999-07-29
SI0882044T1 (en) 2002-10-31
EP0882044B1 (en) 2002-07-17
BR9707568A (pt) 1999-07-27
EP0882044A1 (en) 1998-12-09

Similar Documents

Publication Publication Date Title
US5202335A (en) Succinic acid compounds
JP5778353B2 (ja) アゼチジン化合物、組成物及び可溶性エポキシド加水分解酵素の阻害剤としてのそれらの使用
JP3258297B2 (ja) 抗血栓症薬
TW201726659A (zh) 作為己酮糖激酶抑制劑之經取代3-氮雜雙環[3.1.0]己烷
CN105801489B (zh) 环烷基取代的咪唑衍生物
US7399779B2 (en) 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists
TW201018661A (en) Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
JP2006500370A (ja) Ｐｄｅ４阻害剤としての、ピロリジンジオンにより置換されたピペリジン−フタラゾン
CN1293674A (zh) 三唑并衍生物和含有它们作为有效组分的趋化因子抑制剂
JPH01316363A (ja) ピペラジン誘導体およびその塩
MXPA03001204A (es) 1,4-dihidripiridinas como antagonistas de bradiquinina.
JPWO2004037812A1 (ja) 複素環式化合物及びそれを有効成分とする抗腫瘍剤
JP2004512323A (ja) Ｃｃｒ５ケモカイン受容体活性のピロリジンモジュレーター
CZ324292A3 (en) Quinoline derivatives, process of their preparation and pharmaceutical compositions in which said derivatives are comprised
JPWO2005030773A1 (ja) 新規ピラゾロピリミジン誘導体
TW200800895A (en) Novel compounds
AU689587B2 (en) Dihygropyridine derivatives as bradykinin antagonists
KR0152299B1 (ko) 시클로헵트이미다졸 유도체, 그의 제조방법 및 이 화합물을 함유하는 치료제
OA10712A (en) 1,4-Dihydropyridine compounds as bradykinin antagonists
US6156752A (en) Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
JP6471153B2 (ja) アルドステロン合成酵素阻害剤としての新規フェニルジヒドロピリジン誘導体
AU2003302665A1 (en) Kinase modulators
JP6426697B2 (ja) 尿素誘導体及びその脂肪酸結合タンパク質（ｆａｂｐ）阻害剤としての使用
BE1009376A4 (fr) Derives du carboxymethylidenecycloheptimidazole, procede de preparation de ces derniers et agents therapeutiques contenant ces composes.
EP0790239A1 (en) Novel 4-phenyl-2-(piperazinyl/perhydrodiazepinyl/aminoalkyl)carbonylmethyl)-1,4-dihydropyridine-3,5-dicarboxylic acid derivatives as bradykinin receptor antagonists